Skip to main content
. 2020 Feb 3;11(3):698–709. doi: 10.1002/jcsm.12547

Table 1.

Characteristics of the participants according to the four menopausal status groups

Participant characteristics

Pre

n = 235

EarlyPeri

n = 180

LatePeri

n = 193

Post

n = 289

P for trend
Age, year 50.6 (1.6) 50.7 (1.8) 51.7 (1.9) 52.6 (1.9) <0.001
E2 (nmol/L) 0.627 (0.667) 0.403 (0.318) 0.262 (0.186) 0.144 (0.100) <0.001
FSH (UI/L) 7.9 (3.5) 16.8 (4.8) 45.1 (20.1) 82.4 (28.4) <0.001
Weight, kg 70.0 (10.0) 70.5 (11.3) 70.7 (11.0) 68.5 (11.1) 0.13
Height, cm 166 (5.3) 165 (5.5) 165 (6.0) 165 (6.0) 0.23
BMI 25 (3) 26 (4) 26 (4) 25 (4) 0.11
Fat mass, kg 24.4 (8.0) 25.3 (8.7) 26.3 (8.6) 24.4 (8.5) 0.06
Grip force, N 323.4 (60.6) 323.4 (61.3) 312.3 (61.2) 298.9 (54.2) <0.001
Education, n (%) 0.11a
Primary 1 (0.4) 3 (1.7) 5 (3) 8 (3)
Secondary 128 (55) 99 (55) 96 (50) 179 (62)
Bachelor 27 (12) 24 (13) 26 (14) 41 (14)
Master 64 (27) 43 (24) 54 (28) 49 (17)
Doctoral 14 (6) 10 (6) 11 (6) 11 (4)
Smoking, n (%) 0.83a
Never 156 (67) 122 (68) 123 (64) 194 (67)
Former 63 (27) 45 (25) 49 (26) 73 (25)
Current 14 (6) 12 (7) 19 (10) 21 (7)
Hormonal contraception, n (%) <0.001a
Never 90 (39) 94 (53) 110 (57) 160 (56)
Former 36 (15) 27 (15) 28 (15) 54 (19)
Currentb 108 (46) 58 (32) 54 (28) 74 (26)
Musculoskeletal problem, n (%) 78 (33) 63 (35) 77 (40) 99 (34) 0.49a
Previous bone fracture, n (%) 37 (16) 25 (14) 34 (18) 43 (15) 0.77a
Physical activity, n (%) 0.51a
Sedentary 21 (9) 24 (13) 16 (8) 35 (12)
Low 68 (29) 50 (28) 54 (28) 78 (27)
Moderate 90 (39) 70 (39) 90 (47) 118 (41)
High 55 (24) 35 (20) 32 (17) 57 (20)

Mean and (standard deviation) for the continuous variables and number of participants (n) and percentages (%) for the categorical variables.

BMI, body mass index; E2, 17β‐estradiol; FSH, follicle‐stimulating hormone.

a

χ2 test.

b

95% used intrauterine device and 5% minipills.